MedChina Healthcare News

Between January and June 2025, 74 surgical robots were successfully procured by public hospitals across China. MedRobot presents a sectoral breakdown and insights into market trends, brand performance, and what to expect for the remainder of the year.

Robotrak secures Series C funding to advance its high-precision ophthalmic imaging and laser systems, accelerating global commercialization of its Mona IV and Aglaia 577 platforms.

Lancet Robotics, a leading Chinese surgical robotics company, has raised a multi-million dollar A+ round to accelerate its product innovation and global market expansion.

Boston Scientific launches the Vercise Genus™ DBS System in China, introducing a next-generation, precision-driven solution for Parkinson’s care with real-time visualization and long-lasting therapeutic support.

WEGO Blood Purification raises $150 million in its Shanghai Stock Exchange debut to boost smart manufacturing and R&D in China's dialysis market.

Xellar Biosystems secures strategic investment from XtalPi to pioneer AI-organ chip integration, aiming to revolutionize drug discovery with human-relevant, animal-free testing solutions.

China’s Surgerii Robotics single-port surgical robot achieves NMPA approval for four major specialties, enabling minimally invasive breakthroughs in thoracic and general surgery.

Gaush Meditech Ltd. announced NMPA approval for the Heidelberg ANTERION ophthalmic diagnostic system in China.

Beijing's 2025 policy breakthrough accelerates surgical robot adoption through R&D support, leasing models and DRG reforms, creating new opportunities in China's healthcare market.

Beijing-based Yellwin Medical has completed its Series A++ funding round, raising tens of millions of RMB.

Hangzhou-based Lynmou Medical has successfully closed its Series A funding round, raising tens of millions of RMB.